In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback